Cinctive Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-87,487
Closed -$4.65M 493
2022
Q3
$4.65M Buy
87,487
+28,388
+48% +$1.51M 0.19% 174
2022
Q2
$3.45M Buy
+59,099
New +$3.45M 0.14% 208